首页> 外国专利> PHARMACEUTICAL COMPOSITIONS COMBINING A NONSTEROIDAL ANTI-INFLAMMATORY AGENT AND A XANTHINE OXIDASE INHIBITING AGENT, WHICH CAN BE USED TO CONTROL AND TREAT GOUT, GOUTY ARTHRITIS AND RELATED DISEASES

PHARMACEUTICAL COMPOSITIONS COMBINING A NONSTEROIDAL ANTI-INFLAMMATORY AGENT AND A XANTHINE OXIDASE INHIBITING AGENT, WHICH CAN BE USED TO CONTROL AND TREAT GOUT, GOUTY ARTHRITIS AND RELATED DISEASES

机译:结合非甾体类抗炎药和黄嘌呤氧化酶抑制剂的药物组合物,可用于控制和治疗痛风,痛风性关节炎和相关疾病

摘要

The invention relates to a pharmaceutical composition comprising the synergic combination of a nonsteroidal anti-inflammatory agent known as meloxicam or celecoxib and a xanthine oxidase inhibiting agent know as allopurinol, as well as pharmaceutically acceptable excipients, which are formulated in a single dosage unit to be administered orally. The compositions, which are used to control and treat gouty disease or gout, gouty arthritis and other related diseases, provide an improved therapeutic effect and faster pharmacological action in less time, reducing pain, inflammation and plasma urate levels, as well as providing reductions in the doses administered, the risk of severe complications and the risk of side effects.
机译:本发明涉及药物组合物,其包含被称为美洛昔康或塞来昔布的非甾体抗炎剂和被称为别嘌呤醇的黄嘌呤氧化酶抑制剂的协同组合,以及药学上可接受的赋形剂,其被配制成单个剂量单位以待配伍。口服。用于控制和治疗痛风性疾病或痛风,痛风性关节炎和其他相关疾病的组合物可在更短的时间内提供改善的治疗效果和更快的药理作用,减少疼痛,炎症和血浆尿酸水平,并降低给药剂量,严重并发症的风险和副作用的风险。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号